(0.17%) 5 163.75 points
(0.14%) 38 887 points
(0.15%) 18 028 points
(1.17%) $79.02
(-0.19%) $2.14
(0.93%) $2 330.10
(2.45%) $27.34
(0.70%) $972.05
(-0.06%) $0.928
(-0.28%) $10.84
(-0.26%) $0.795
(-0.02%) $91.44
0.95% $ 81.69
Live Chart Being Loaded With Signals
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software...
Stats | |
---|---|
Объем за сегодня | 4.99M |
Средний объем | 6.36M |
Рыночная капитализация | 108.47B |
EPS | $0 ( 2024-04-07 ) |
Дата следующего отчета о доходах | ( $1.450 ) 2024-05-23 |
Last Dividend | $0.690 ( 2023-09-21 ) |
Next Dividend | $0 ( N/A ) |
P/E | 25.93 |
ATR14 | $0.0310 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Powell Kendall J | Sell | 192 | Ordinary Shares |
2024-05-01 | Oleary Denise M | Sell | 192 | Ordinary Shares |
2024-05-01 | Nabel Elizabeth G | Sell | 192 | Ordinary Shares |
2024-05-01 | Lofton Kevin E | Sell | 192 | Ordinary Shares |
2024-05-01 | Hogan Randall J | Sell | 192 | Ordinary Shares |
INSIDER POWER |
---|
70.97 |
Last 100 transactions |
Buy: 1 291 792 | Sell: 191 147 |
Объем Корреляция
Medtronic PLC Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Medtronic PLC Корреляция - Валюта/Сырье
Medtronic PLC Финансовые показатели
Annual | 2023 |
Выручка: | $31.23B |
Валовая прибыль: | $20.51B (65.67 %) |
EPS: | $2.85 |
FY | 2023 |
Выручка: | $31.23B |
Валовая прибыль: | $20.51B (65.67 %) |
EPS: | $2.85 |
FY | 2023 |
Выручка: | $31.23B |
Валовая прибыль: | $20.51B (65.67 %) |
EPS: | $2.83 |
FY | 2022 |
Выручка: | $31.69B |
Валовая прибыль: | $21.54B (67.98 %) |
EPS: | $3.75 |
Financial Reports:
No articles found.
Medtronic PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.680 (N/A) |
$0.680 (N/A) |
$0.680 (N/A) |
$0.690 (N/A) |
$0.690 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00219 | 1982-01-04 |
Last Dividend | $0.690 | 2023-09-21 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-13 | |
Next Payout Date | N/A | |
# dividends | 167 | -- |
Total Paid Out | $27.99 | -- |
Avg. Dividend % Per Year | 1.62% | -- |
Score | 5.08 | -- |
Div. Sustainability Score | 9.19 | |
Div.Growth Potential Score | 3.66 | |
Div. Directional Score | 6.43 | -- |
Year | Amount | Yield |
---|---|---|
1982 | $0.00938 | 1.55% |
1983 | $0.0106 | 1.26% |
1984 | $0.0116 | 1.72% |
1985 | $0.0122 | 2.89% |
1986 | $0.0131 | 1.94% |
1987 | $0.0150 | 1.24% |
1988 | $0.0134 | 0.90% |
1989 | $0.0203 | 1.67% |
1990 | $0.0238 | 1.16% |
1991 | $0.0286 | 1.09% |
1992 | $0.0325 | 0.56% |
1993 | $0.0387 | 0.65% |
1994 | $0.0595 | 1.15% |
1995 | $0.0454 | 0.68% |
1996 | $0.0802 | 0.62% |
1997 | $0.103 | 0.61% |
1998 | $0.120 | 0.48% |
1999 | $0.145 | 0.40% |
2000 | $0.181 | 0.53% |
2001 | $0.215 | 0.36% |
2002 | $0.299 | 0.60% |
2003 | $0.280 | 0.60% |
2004 | $0.243 | 0.50% |
2005 | $0.362 | 0.73% |
2006 | $0.413 | 0.71% |
2007 | $0.470 | 0.89% |
2008 | $0.813 | 1.64% |
2009 | $0.598 | 1.83% |
2010 | $0.860 | 1.96% |
2011 | $0.936 | 2.50% |
2012 | $1.266 | 3.27% |
2013 | $1.100 | 2.63% |
2014 | $1.195 | 2.09% |
2015 | $1.445 | 2.01% |
2016 | $1.670 | 2.20% |
2017 | $1.810 | 2.56% |
2018 | $1.460 | 1.78% |
2019 | $2.12 | 2.41% |
2020 | $2.28 | 1.99% |
2021 | $2.47 | 2.13% |
2022 | $2.67 | 2.52% |
2023 | $2.06 | 2.63% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.130 | 1.500 | 7.40 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0462 | 1.200 | 8.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0816 | 1.500 | -0.204 | -0.307 | [0.1 - 1] |
payoutRatioTTM | 0.871 | -1.000 | 1.293 | -1.293 | [0 - 1] |
currentRatioTTM | 2.30 | 0.800 | 3.51 | 2.80 | [1 - 3] |
quickRatioTTM | 1.459 | 0.800 | 6.12 | 4.90 | [0.8 - 2.5] |
cashRatioTTM | 0.166 | 1.500 | -0.190 | -0.286 | [0.2 - 2] |
debtRatioTTM | 0.277 | -1.500 | 5.39 | -8.08 | [0 - 0.6] |
interestCoverageTTM | 8.05 | 1.000 | 8.13 | 8.13 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.15 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.485 | -1.500 | 8.06 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.655 | 1.000 | 2.42 | 2.42 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.175 | 1.000 | 8.50 | 8.50 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.258 | 1.000 | 9.68 | 9.68 | [0.2 - 2] |
assetTurnoverTTM | 0.356 | 0.800 | -0.961 | -0.769 | [0.5 - 2] |
Total Score | 9.19 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.86 | 1.000 | 7.49 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0816 | 2.50 | -0.131 | -0.307 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.76 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.38 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.871 | 1.500 | 1.293 | -1.293 | [0 - 1] |
pegRatioTTM | -1.054 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.200 | 1.000 | 7.50 | 0 | [0.1 - 0.5] |
Total Score | 3.66 |
Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа